Cresco Labs Inc (CL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,564 | 103,429 | 119,341 | 223,543 | 136,339 |
| Receivables | 51,563 | 52,491 | 56,939 | 44,691 | 31,704 |
| Inventories | 83,343 | 107,789 | 134,608 | 136,643 | 182,654 |
| Other current assets | 5,667 | 7,961 | 5,738 | 16,878 | 11,057 |
| TOTAL | $294,257 | $278,087 | $326,046 | $421,755 | $361,754 |
| Non-Current Assets | |||||
| PPE Net | 455,503 | 486,190 | 507,986 | 457,109 | 287,400 |
| Investments And Advances | N/A | 730 | 1,228 | 5,912 | 4,360 |
| Intangibles | 577,478 | 576,663 | 738,145 | 884,411 | 647,379 |
| Other Non-Current Assets | 28,117 | 16,797 | 10,287 | 11,276 | 32,231 |
| TOTAL | $1,061,098 | $1,080,380 | $1,257,646 | $1,358,708 | $971,370 |
| Total Assets | $1,355,355 | $1,358,467 | $1,583,692 | $1,780,463 | $1,333,124 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,325 | 9,813 | 9,500 | 19,928 | 15,046 |
| Accounts payable and accrued liabilities | 13,651 | 27,587 | 28,093 | 32,278 | 26,170 |
| Accrued Expenses | 54,296 | 69,079 | 65,161 | 95,442 | 49,701 |
| Other current liabilities | N/A | N/A | N/A | 1,172 | N/A |
| TOTAL | $94,338 | $200,242 | $280,866 | $288,394 | $194,640 |
| Non-Current Liabilities | |||||
| Long Term Debt | 460,750 | 497,713 | 469,055 | 465,079 | 169,475 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,182 |
| Other Non-Current Liabilities | 304,485 | 105,802 | 54,126 | -17,530 | -104,379 |
| TOTAL | $872,841 | $730,158 | $715,143 | $694,333 | $413,726 |
| Total Liabilities | $967,179 | $930,400 | $996,009 | $982,727 | $608,366 |
| Shareholders' Equity | |||||
| Common Shares | 1,706,822 | 1,689,452 | 1,704,630 | 1,597,715 | 826,341 |
| Retained earnings | -1,352,486 | -1,265,536 | -1,076,198 | -841,907 | -286,197 |
| Other shareholders' equity | -2,232 | -1,151 | -1,393 | -254 | -621 |
| TOTAL | $474,854 | $505,692 | $627,039 | $755,554 | $574,446 |
| Total Liabilities And Equity | $1,442,033 | $1,436,092 | $1,623,048 | $1,738,281 | $1,182,812 |